Therapy: Risks associated with chronic PPI use - signal or noise? - PubMed

Comment

Therapy: Risks associated with chronic PPI use - signal or noise?

Leila Kia et al. Nat Rev Gastroenterol Hepatol. 2016 May.

Comment on

• Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

  Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Lazarus B, et al. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193. JAMA Intern Med. 2016. PMID: 26752337 Free PMC article.

Similar articles

• Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.

  Gyawali CP. Gyawali CP. Curr Gastroenterol Rep. 2017 Sep;19(9):46. doi: 10.1007/s11894-017-0586-5. Curr Gastroenterol Rep. 2017. PMID: 28780717 Review.

• Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.

  Hermos JA, Young MM, Fonda JR, Gagnon DR, Fiore LD, Lawler EV. Hermos JA, et al. Clin Infect Dis. 2012 Jan 1;54(1):33-42. doi: 10.1093/cid/cir767. Epub 2011 Nov 18. Clin Infect Dis. 2012. PMID: 22100573

• Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.

  Jackson LR 2nd, Peterson ED, McCoy LA, Ju C, Zettler M, Baker BA, Messenger JC, Faries DE, Effron MB, Cohen DJ, Wang TY. Jackson LR 2nd, et al. J Am Heart Assoc. 2016 Oct 21;5(10):e003824. doi: 10.1161/JAHA.116.003824. J Am Heart Assoc. 2016. PMID: 27792656 Free PMC article.

• Strategies for Effective Discontinuation of Proton Pump Inhibitors.

  Kim J, Blackett JW, Jodorkovsky D. Kim J, et al. Curr Gastroenterol Rep. 2018 May 16;20(6):27. doi: 10.1007/s11894-018-0632-y. Curr Gastroenterol Rep. 2018. PMID: 29767318 Review.

• Proton pump inhibitors: the good, the bad, and the unwanted.

  Chubineh S, Birk J. Chubineh S, et al. South Med J. 2012 Nov;105(11):613-8. doi: 10.1097/SMJ.0b013e31826efbea. South Med J. 2012. PMID: 23128806 Review.

Cited by

• Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.

  Sun N, Zhang Y, Ding L, An X, Bai F, Yang Y, Yu K, Fan J, Liu L, Yang H, Yang X. Sun N, et al. J Mol Med (Berl). 2024 May;102(5):679-692. doi: 10.1007/s00109-024-02429-5. Epub 2024 Mar 8. J Mol Med (Berl). 2024. PMID: 38453697

• Chinese herbal medicine for functional dyspepsia: a network meta-analysis of prokinetic-controlled randomised trials.

  Ho L, Zhong CCW, Wong CHL, Wu JCY, Chan KKH, Wu IXY, Leung TH, Chung VCH. Ho L, et al. Chin Med. 2021 Dec 20;16(1):140. doi: 10.1186/s13020-021-00556-6. Chin Med. 2021. PMID: 34930390 Free PMC article. Review.

• Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease.

  Kahrilas P, Yadlapati R, Roman S. Kahrilas P, et al. F1000Res. 2017 Sep 25;6:1748. doi: 10.12688/f1000research.11918.1. eCollection 2017. F1000Res. 2017. PMID: 29034088 Free PMC article. Review.

• Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.

  Brusselaers N, Lagergren J. Brusselaers N, et al. BMJ Open. 2018 Jul 7;8(7):e021869. doi: 10.1136/bmjopen-2018-021869. BMJ Open. 2018. PMID: 29982219 Free PMC article.

• Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.

  Gyawali CP. Gyawali CP. Curr Gastroenterol Rep. 2017 Sep;19(9):46. doi: 10.1007/s11894-017-0586-5. Curr Gastroenterol Rep. 2017. PMID: 28780717 Review.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • scite Smart Citations